Shaping Humanity's Cognitive Future
J.L. Mee is a leading innovator in the emerging field of human cognitive enhancement. As a futurist, his cognitive economics theory helps progressive leaders understand the macroeconomic and technology trends which are shaping this transformative new industry.
As an inventor, his cognitive neuroengineering technology provides a powerful and versatile platform for leveraging genome editing techniques to improve mental health, acuity and cognition.
Change often comes from mavericks who think outside the box and work outside the system. The Wright Brothers were bicycle builders. Edison was a telegraph operator. Tesla was a draftsman. James Watt was an instrument maker. The greatest architect of the early Renaissance, Filippo Brunelleschi, was a jeweler. William Boeing was a lumber company executive. Genentech founder Bob Swanson had no formal training in biology. Michael Faraday was a bookbinder. The list goes on. All of these men changed history with dynamic innovations which came from outside the established channels of thought.
Futurist
The Genetic Age dawning today will experience a power growth curve similar to the Information Age. Semiconductors changed the world, and forward-thinking families who took early positions in the computer industry were lifted into eminence.
Genetic engineering is the next frontier. New technologies are being developed to apply the power of genetic engineering to improving mental health and cognition. The Cognitive Economics market intelligence report helps visionary leaders understand how these breakthroughs can be leveraged to enrich humanity's cognitive capital.
Times like this of great transition are often rife with opportunity, as genomic engineering will eventually become one of the world’s largest industries.
Cognitive competency meets crucial needs in our society. To thrive in this century of global competition, American entrepreneurs require more innovation, more creative solutions, and more exceptional thinking. Generation Z in particular needs a mental edge and expanded human value skills such as imagination and creativity to stay ahead of competition for jobs from robotics, A.I. and China. Genetic upgrades can deliver the cognitive resources for meeting these needs.
Success in today’s world requires bold, decisive action based on keen insights into revolutionary trends. Forward-thinking leaders can be on the winning side of change by becoming early adopters and innovators who turn potential into opportunity.
"The world today is shifting into an innovation economy where cognitive capital is the prime currency.
In the 21st Century, the ability to marshal this precious resource for creative problem solving will determine the economic mobility of individuals and the wealth of nations."
– J.L. Mee
In 2017, Mr. Mee discovered a master control switch for consciousness in the human genome.
He invented scientific methods for modifying this gene to improve cognition, filed patents, secured partners, built a company, recruited a blue ribbon team of top-notch neuroscientists, raised angel and venture financing, and developed a product.
The company conducted 25 preclinical research experiments which conclusively demonstrated the product's efficacy in animal models; reducing anxiety by 34% and improving memory by 94%.
The results were published in top-tier scientific journals, and the research is proceeding towards first in-human use.Th
The ability to form memories is largely a function of attention.
In neuroscience, attention in mice is regarded as a proxy for awareness in humans.
Thus, we may be at the threshold of creating new states of consciousness.
The company's technology has been validated:
● in multiple indications (1)
● in multiple species (2)
● using multiple gene editors (3)
● on multiple targets (4)
● for multiple genes (5).
Results have been
● replicated across multiple behavioral models (6) and
● validated in multiple diagnostic assays (7)
● on multiple neuron types (8).
Inventor
J.L. Mee holds multiple patents pending on genetic engineering methods for enhancing human cognition. These discoveries form the enabling technology for expanding human cognitive capital to meet the challenges of the 21st Century; boosting mental health, attention, focus, creativity, memory and mental acuity.
With co-inventors Dr. Dean Radin and Dr. James Fallon, Mr. Mee developed a revolutionary new dynamic delivery platform systems architecture for precisely transporting gene therapies to any localized brain region. This discovery can be applied to alleviate neurological conditions by targeting specific brain areas.
● Neurological disorders: Dynamic delivery will enable dozens of clinical applications for addressing a wide spectrum of neurological conditions without the side effects of pharmaceuticals. Treatable conditions include stress, anxiety, depression, obsessive-compulsive disorder (OCD), attention deficit disorder (ADD), mild cognitive impairment (MCI) and memory issues. These disorders typically involve imbalances in various brain regions, and their behavioral and cognitive effects can be mitigated by normalizing the unbalanced areas.
● Cognitive enrichment: Dynamic delivery can also be used to improve memory, reverse cognitive decline, decrease inattention, reduce mind-wandering, lower craving, sharpen mental focus, increase concentration, and foster emotional balance.
● Platform technology: The Mee-Radin patent for dynamic delivery architecture is a foundational science breakthrough. Due to its breadth of application, this technology can form the bedrock for a cognitive treatment and enhancement ecosystem which can have far-reaching effects on human mental health, cognitive capacity and overall well-being.
Mission
The neurotech company John Mee founded, Cognigenics, is developing and implementing a 21st Century mental health science based upon the latest genetic engineering technologies. The firm builds shareholder value by expanding its portfolio of intellectual property through innovative research and experimentation.
Conclusions
The advent of next-generation mental health technology represents a defining moment in the progress of medicine. Visionary leadership will be required to achieve the full promise of cognitive neuroengineering, and it will be up to progressive business, financial and engineering leaders to maximize the potential of this transformative technology.